Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 28, 2020
Humanigen announced a strategic collaboration with Thermo Fisher Scientific to expand the manufacturing capacity for lenzilumab, currently in a Phase 3 registration study in patients with COVID-19.
read more
Monday, September 28, 2020
T-knife GmbH and Catalent announced they have signed an agreement to provide technology transfer and CGMP clinical manufacturing of T-knife’s T1367 T-cell receptor program.
read more
Friday, September 25, 2020
The FDA is alerting health care professionals and patients of a recall of all unexpired albuterol sulfate inhalation aerosol manufactured by Catalent for Perrigo due to possible clogging of the inhaler.
read more
Friday, September 25, 2020
JRS PHARMA has announced the Rettenmaier Natural Fiber Manufacturing facilities in Changzhou, China, were awarded an EXCiPACT™ Certificate for Good Manufacturing Practices (GMP).
read more
Thursday, September 24, 2020
Sobrera and Recipharm have entered into an agreement for the formulation development and manufacturing of SO-001, a new oral treatment for Alcohol Use Disorder.
read more
Wednesday, September 23, 2020
BioNTech announced the signing of a share purchase agreement with Novartis AG, Basel / Switzerland to acquire their GMP certified manufacturing facility in Marburg, Germany.
read more
Wednesday, September 23, 2020
JRS PHARMA has announced the Rettenmaier Natural Fiber Manufacturing facilities in Changzhou, China, were awarded an EXCiPACT™ Certificate for GMP.
read more
Tuesday, September 22, 2020
Aphena Pharma Solutions has announced a $21 million expansion of its Solid Dose Division in Cookeville, Tennessee, with the acquisition of a 500,000-square-foot property, purpose-built for FDA manufacturing and packaging operations.
read more
Tuesday, September 22, 2020
Seqens CDMO North America has appointed Jean-Noel David as Managing Director for North America.
read more
Monday, September 21, 2020
Alimera Sciences Europe has signed a distribution agreement with Medis for the exclusive sales and distribution of ILUVIEN in the Czech Republic and Austria.
read more
Monday, September 21, 2020
BioNTech will receive a grant by the German Federal Ministry of Education and Research to support the accelerated development of SARS-CoV-2 vaccines.
read more
Wednesday, September 16, 2020
Sai Life Sciences announced the addition of cellular analysis platforms at its Discovery Biology facility in Cambridge, Massachusetts, USA.
read more
Wednesday, September 16, 2020
The FDA has issued a temporary guidance, “Resuming Normal Drug and Biologics Manufacturing Operations During the COVID-19 Public Health Emergency.”
read more
Wednesday, September 16, 2020
Valneva and Dynavax announced a commercial partnership for the supply of Dynavax's CpG 1018 adjuvant for use in Valneva's SARS-CoV-2 vaccine candidate, VLA2001.
read more
Tuesday, September 15, 2020
Cobra Biologics and CombiGene have signed agreements covering GMP production of two essential plasmids needed for the manufacture of a gene therapy for drug resistant focal epilepsy.
read more